tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

Compare NewAmsterdam Pharma Company (NAMS) vs. Competitors

249 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$34.76
$4.00B
-19.69
133.29%
11 Buy
0 Hold
0 Sell
Strong Buy
Viking Therapeutics
$34.26
$3.96B
-6.36
59.20%
12 Buy
0 Hold
0 Sell
Strong Buy
Xenon
$58.40
$5.57B
-10.27
90.04%
19 Buy
0 Hold
0 Sell
Strong Buy
Soleno Therapeutics
$52.63
$2.72B
117.86
-16.29%
3 Buy
10 Hold
0 Sell
Hold
Kiniksa Pharmaceuticals
$47.08
$3.60B
51.87
152.44%
6 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$24.50
$4.99B
-10.43
65.65%
10 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
34.76
18.34
111.69%
VKTX
Viking Therapeutics
34.26
9.69
39.44%
XENE
Xenon
58.40
24.96
74.64%
SLNO
Soleno Therapeutics
52.63
-17.37
-24.81%
KNSA
Kiniksa Pharmaceuticals
47.08
26.39
127.55%
IMVT
Immunovant
24.50
9.07
58.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts